News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,611 Results
Type
Article (42149)
Company Profile (268)
Press Release (692179)
Multimedia
Podcasts (92)
Webinars (21)
Section
Business (205674)
Career Advice (2049)
Deals (35648)
Drug Delivery (132)
Drug Development (81700)
Employer Resources (173)
FDA (16557)
Job Trends (15051)
News (348007)
Policy (32862)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2645)
Academic (1)
Accelerated approval (48)
Adcomms (27)
Allergies (171)
Alliances (49891)
ALS (213)
Alzheimer's disease (1806)
Antibody-drug conjugate (ADC) (460)
Approvals (16950)
Artificial intelligence (675)
Autoimmune disease (297)
Automation (56)
Bankruptcy (364)
Best Places to Work (11665)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (174)
Bladder cancer (197)
Brain cancer (72)
Breast cancer (758)
Cancer (5888)
Cardiovascular disease (477)
Career advice (1740)
Career pathing (44)
CAR-T (334)
CDC (56)
Celiac Disease (3)
Cell therapy (910)
Cervical cancer (47)
Clinical research (71025)
Collaboration (2079)
Company closure (5)
Compensation (1408)
Complete response letters (80)
COVID-19 (2759)
CRISPR (109)
C-suite (1142)
Cystic fibrosis (152)
Data (8011)
Decentralized trials (3)
Denatured (28)
Depression (161)
Dermatology (87)
Diabetes (590)
Diagnostics (6973)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (324)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (285)
Earnings (92223)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (120082)
Executive appointments (1086)
FDA (20311)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1753)
Gene editing (235)
Generative AI (56)
Gene therapy (725)
GLP-1 (1057)
Government (4762)
Grass and pollen (6)
Guidances (408)
Healthcare (19052)
HIV (81)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (289)
Immuno-oncology (93)
Indications (196)
Infectious disease (3106)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (293)
Interviews (322)
IPO (16689)
IRA (50)
Job creations (3684)
Job search strategy (1444)
JPM (58)
Kidney cancer (19)
Labor market (103)
Layoffs (567)
Leadership (42)
Legal (7974)
Liver cancer (101)
Longevity (32)
Lung cancer (777)
Lymphoma (431)
Machine learning (60)
Management (59)
Manufacturing (1063)
MASH (191)
Medical device (13980)
Medtech (14108)
Mergers & acquisitions (20216)
Metabolic disorders (1511)
mRNA (213)
Multiple sclerosis (189)
NASH (17)
Neurodegenerative disease (423)
Neuropsychiatric disorders (105)
Neuroscience (3334)
Neurotech (1)
NextGen: Class of 2026 (6541)
Non-profit (4559)
Now hiring (78)
Obesity (706)
Opinion (288)
Ovarian cancer (226)
Pain (258)
Pancreatic cancer (308)
Parkinson's disease (367)
Partnered (33)
Patents (600)
Patient recruitment (678)
Peanut (62)
People (59940)
Pharmaceutical (58)
Pharmacy benefit managers (32)
Phase 1 (22172)
Phase 2 (31291)
Phase 3 (23257)
Pipeline (8900)
Policy (322)
Postmarket research (2574)
Preclinical (9452)
Press Release (68)
Prostate cancer (309)
Psychedelics (54)
Radiopharmaceuticals (326)
Rare diseases (1084)
Real estate (6033)
Recruiting (70)
Regulatory (25509)
Reports (56)
Research institute (2459)
Resumes & cover letters (355)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (179)
Series A (292)
Series B (215)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3669)
State (2)
Stomach cancer (18)
Supply chain (128)
Tariffs (88)
The Weekly (62)
Vaccines (1104)
Venture capital (110)
Weight loss (453)
Women's health (128)
Worklife (20)
Date
Today (1)
Last 7 days (675)
Last 30 days (3385)
Last 365 days (30092)
2026 (13091)
2025 (30236)
2024 (35263)
2023 (40144)
2022 (51254)
2021 (55813)
2020 (54211)
2019 (46702)
2018 (35178)
2017 (32286)
2016 (31677)
2015 (37794)
2014 (31496)
2013 (26573)
2012 (28774)
2011 (29459)
2010 (27561)
Location
Africa (746)
Alabama (94)
Alaska (7)
Arizona (350)
Arkansas (14)
Asia (39972)
Australia (6549)
California (13402)
Canada (3799)
China (1363)
Colorado (570)
Connecticut (580)
Delaware (413)
Europe (86459)
Florida (2011)
Georgia (431)
Hawaii (3)
Idaho (62)
Illinois (1059)
India (90)
Indiana (604)
Iowa (23)
Japan (541)
Kansas (131)
Kentucky (51)
Louisiana (42)
Maine (76)
Maryland (1602)
Massachusetts (9568)
Michigan (366)
Minnesota (726)
Mississippi (7)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3517)
New Mexico (29)
New York (3499)
North Carolina (1698)
North Dakota (9)
Northern California (6726)
Ohio (399)
Oklahoma (23)
Oregon (41)
Pennsylvania (2692)
Puerto Rico (29)
Rhode Island (50)
South America (1121)
South Carolina (86)
South Dakota (2)
Southern California (5292)
Tennessee (217)
Texas (2132)
United States (47254)
Utah (398)
Vermont (1)
Virginia (326)
Washington D.C. (80)
Washington State (1068)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
734,611 Results for "saladax biomedical inc sbi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
Saladax Biomedical, Inc. is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil Assay for sale in Canada in a rapid six days.
May 14, 2024
·
2 min read
Press Releases
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
April 5, 2026
·
1 min read
Press Releases
Lifecore Biomedical to Participate at CDMO Live Europe
May 13, 2026
·
1 min read
Press Releases
Catalent and S.Biomedics Announce Partnership to Develop and Manufacture TED‑A9
February 18, 2026
·
3 min read
Press Releases
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
May 21, 2026
·
1 min read
Press Releases
Micron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia
May 21, 2026
·
5 min read
Press Releases
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Pittsburgh
Weinstein Imaging Associates joins as clinical site to collect breath samples to advance development of a breath test for early detection of breast cancer in women
May 5, 2026
·
5 min read
Deals
Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
Saladax Biomedical, Inc. is pleased to announce that it has acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV.
April 5, 2022
·
2 min read
Press Releases
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit
April 8, 2026
·
1 min read
Business
Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests
Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global distribution agreement with Beckman Coulter, Inc. to distribute the MyCare™ Psychiatry Laboratory Assays. The MyCare™ Psychiatry Laboratory Assays measure drug levels of the antipsychotic drugs prescribed to treat patients with serious mental illness (SMI), such as such as Schizophrenia and Bipolar Disorder.
March 15, 2022
·
4 min read
1 of 73,462
Next
